Reaction
Campylobacter Gastroenteritis reporting signals
As of the last recalculation, Campylobacter Gastroenteritis appears in 582 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is BENDAMUSTINE HCL (PRR 47.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bendamustine Hcl | 20 | 47.7 | 47.8 |
| Anti-Thymocyte Globulin (Rabbit) | 7 | 31.4 | 31.4 |
| Valganciclovir | 13 | 25.2 | 25.2 |
| Valganciclovir Hydrochloride | 13 | 25.2 | 25.2 |
| Valganciclovir Hydrochloride Powder, | 8 | 23.8 | 23.8 |
| Filgrastim | 23 | 22.7 | 22.7 |
| Loperamide Hydrochloride Oral | 6 | 21.2 | 21.2 |
| Teduglutide | 7 | 18.8 | 18.8 |
| Entecavir | 5 | 15.4 | 15.4 |
| Polatuzumab Vedotin | 4 | 14.8 | 14.8 |
| Axicabtagene Ciloleucel | 4 | 14.6 | 14.6 |
| Panitumumab | 6 | 13.8 | 13.8 |
| Venetoclax | 21 | 12.6 | 12.6 |
| Obinutuzumab | 5 | 11.0 | 11.0 |
| Trifluridine And Tipiracil | 3 | 10.0 | 10.0 |
| Ixazomib | 6 | 7.5 | 7.5 |